Free Trial
LON:SBTX

SkinBioTherapeutics (SBTX) Share Price, News & Analysis

SkinBioTherapeutics logo
GBX 14.25 0.00 (0.00%)
As of 03:43 AM Eastern

About SkinBioTherapeutics Stock (LON:SBTX)

Key Stats

Today's Range
14.12
14.25
50-Day Range
13.82
17
52-Week Range
9
27.50
Volume
256,076 shs
Average Volume
1.22 million shs
Market Capitalization
£36.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBTX Stock News Headlines

How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
See More Headlines

SBTX Stock Analysis - Frequently Asked Questions

SkinBioTherapeutics' stock was trading at GBX 18.49 at the start of the year. Since then, SBTX shares have decreased by 22.9% and is now trading at GBX 14.25.

SkinBioTherapeutics plc (LON:SBTX) posted its quarterly earnings results on Wednesday, March, 26th. The company reported ($0.46) earnings per share (EPS) for the quarter. SkinBioTherapeutics had a negative net margin of 237.95% and a negative trailing twelve-month return on equity of 115.86%.

Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that SkinBioTherapeutics investors own include OptiBiotix Health (OPTI), Ecora Resources (ECOR), Avacta Group (AVCT), Inspired (INSE), Lb-shell (LBP), Anglo African Oil & Gas (AAOG) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
3/26/2025
Today
9/01/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:SBTX
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£3.71 million
Net Margins
-237.95%
Pretax Margin
N/A
Return on Equity
-115.86%
Return on Assets
-61.18%

Debt

Debt-to-Equity Ratio
27.57
Current Ratio
0.93
Quick Ratio
10.01

Sales & Book Value

Annual Sales
£2.68 million
Price / Sales
13.77
Cash Flow
GBX 1.58 per share
Price / Cash Flow
9.00
Book Value
GBX 1.68 per share
Price / Book
8.49

Miscellaneous

Outstanding Shares
258,779,000
Free Float
N/A
Market Cap
£36.88 million
Optionable
Not Optionable
Beta
2.01
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:SBTX) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners